Forward Ventures

Type

Venture Capital

Status

Active

Location

San Diego, United States

Total investments

63

Average round size

26M

Portfolio companies

34

Rounds per year

2.17

Lead investments

4

Follow on index

0.46

Exits

19

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryHealth CareMedical DeviceMedicalPharmaceuticalTherapeuticsWomen'sBiopharmaClinical Trials

Summary

Forward Ventures appeared to be the VC, which was created in 1993. The leading representative office of defined VC is situated in the San Diego. The company was established in North America in United States.

The fund was created by Standish M. Fleming. The overall number of key employees were 2.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Forward Ventures, startups are often financed by Domain Associates, Gimv, Alta Partners. The meaningful sponsors for the fund in investment in the same round are Alta Partners, Gimv, Roche Venture Fund. In the next rounds fund is usually obtained by Alta Partners, Gimv, Domain Associates.

Comparing to the other companies, this Forward Ventures performs on 3 percentage points less the average number of lead investments. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Forward Ventures the average startup value is 10-50 millions dollars. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2007. The fund is constantly included in 2-6 deals per year.

The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Tioga Pharmaceuticals, Viracta Therapeutics, Affinium Pharmaceuticals Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesHealthcareMedtech
Stage focus
GeneralistPre-SeedSeedSeries ASeries B Show 3 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 75000000

Analytics

Total investments
63
Lead investments
4
Exits
19
Rounds per year
2.17
Follow on index
0.46
Investments by industry
  • Biotechnology (49)
  • Health Care (37)
  • Medical (24)
  • Pharmaceutical (23)
  • Therapeutics (17)
  • Show 33 more
Investments by region
  • United States (60)
  • Canada (1)
  • United Kingdom (2)
Peak activity year
2007
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
95M
Group Appearance index
0.98
Avg. company exit year
8
Avg. multiplicator
2.58
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
TargeGen 31 May 2002 Biotechnology, Health Care, Biopharma Early Stage Venture 10M United States, California, San Diego
Xanadu 09 Nov 2022 Software, Artificial Intelligence, Big Data, Hardware, Quantum Computing Late Stage Venture 100M Ontario, Old Toronto, Canada

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.